Last reviewed · How we verify
NCT07512856
The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
NA trial testing Transgender-tailored Harm Reduction Service in HIV Prevention in 140 participants. Currently enrolling.
1 February 2027
Quick facts
| Lead sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 1 February 2024 |
| Primary completion | 1 February 2027 |
| Estimated completion | 1 February 2028 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Transgender-tailored Harm Reduction Service
Conditions studied
- HIV Prevention — all drugs for HIV Prevention →
- Substance Use — all drugs for Substance Use →
- Mental Health Disorders — all drugs for Mental Health Disorders →
- Sexually Transmitted Infections (STIs) — all drugs for Sexually Transmitted Infections (STIs) →
Sponsor
Institute of HIV Research and Innovation Foundation, Thailand
Who can join
18 and older, any sex, with HIV Prevention or Substance Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07512856
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HIV Prevention
Currently open trials in the same condition.
- NCT07194902 — HIV Self-testing for Partners of HIV-uninfected Postpartum Women · NA · recruiting
- NCT07218211 — Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP · Phase 4 · recruiting
- NCT07349758 — Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers · Phase 1 · recruiting
- NCT07433985 — California MEPS Hub · NA · recruiting
- NCT07002866 — Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda · NA · recruiting
Other Institute of HIV Research and Innovation Foundation, Thailand trials
Trials by the same sponsor.
- NCT07509853 — Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engag · NA · recruiting
- NCT07512869 — Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Impl · recruiting
- NCT07509827 — Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER) · NA · recruiting
- NCT07505875 — Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX · recruiting
- NCT06741306 — Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07512856 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of HIV Research and Innovation Foundation, Thailand
- Last refreshed: 6 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07512856.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing